Toggle Main Menu Toggle Search

Open Access padlockePrints

Association of Plasma Aβ40 Peptides, but Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus

Lookup NU author(s): Professor Konstantinos StellosORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2016 IOS Press and the authors. All rights reserved. Background/Objective: Plasma levels of amyloid-beta (Aβ) 1-40 peptide have been proposed to be associated with cardiovascular mortality in patients with coronary artery disease (CAD). Therefore, we aimed to investigate the association of plasma Aβ levels with CAD, cardiovascular risk factors (CVRF), and APOE genotype in non-demented elderly individuals. Methods: Plasma Aβ1 - 40 and Aβ1 - 42 levels of 526 individuals (mean age of 63.0±7.3 years) were quantified with the INNO-BIA plasma Aβ forms assay based on multiplextrademark technique. APOE genotype was determined with an established protocol. Presence of CAD and CVRFs were ascertained using a questionnaire and/or medical records. Results: Plasma Aβ1 - 40 levels were significantly higher in individuals with CAD (p = 0.043) and, independently, in individuals with diabetes mellitus (DM) type 2 (p = 0.001) while accounting for age- and gender-effects. Plasma Aβ1 - 42 levels were higher in APOE ϵ4 carriers (p = 0.004), but were neither relevantly associated with CAD nor with any CVRF. Plasma Aβ1 - 40 showed no association with APOE genotype. Discussion: Our findings argue for an association of circulating plasma Aβ1 - 40 peptides with incident CAD and DM. Further investigations are needed to entangle the role of Aβ1 - 40 role in the pathophysiology of cardiovascular disease independent of its known role in Alzheimer's disease.


Publication metadata

Author(s): Roeben B, Maetzler W, Vanmechelen E, Schulte C, Heinzel S, Stellos K, Godau J, Huber H, Brockmann K, Wurster I, Gaenslen A, Gruner E, Niebler R, Eschweiler GW, Berg D

Publication type: Article

Publication status: Published

Journal: Journal of Alzheimer's Disease

Year: 2016

Volume: 52

Issue: 1

Pages: 161-169

Online publication date: 26/04/2016

Acceptance date: 19/01/2016

ISSN (print): 1387-2877

ISSN (electronic): 1875-8908

Publisher: IOS Press

URL: https://doi.org/10.3233/JAD-150575

DOI: 10.3233/JAD-150575

PubMed id: 27003209


Altmetrics

Altmetrics provided by Altmetric


Share